Lasica RM - Search Results

1

Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention.

Matic DM, Asanin MR, Vukcevic VD, Mehmedbegovic ZH, Marinkovic JM, Kocev NI, Marjanovic MM, Mrdovic IB, Antonijevic NM, Milosevic AD, Zivkovic MN, Krljanac GV, Stankovic SD, Milasinovic DG, Lasica RM, Stankovic GR. Matic DM, et al. Among authors: lasica rm. Heart. 2019 Oct;105(20):1568-1574. doi: 10.1136/heartjnl-2019-314728. Epub 2019 May 25. Heart. 2019. PMID: 31129612

2

High-dose streptokinase in the treatment of acute massive pulmonary embolism complicated with cardiogenic shock, respiratory arrest and ventricular fibrillation.

Lasica R, Perunicić J, Mrdović I, Stojanović R, Vasiljević Z. Lasica R, et al. Vojnosanit Pregl. 2005 Jul-Aug;62(7-8):581-5. doi: 10.2298/vsp0508581l. Vojnosanit Pregl. 2005. PMID: 16171023

3

Temporal variations at the onset of spontaneous acute aortic dissection.

Lasica RM, Perunicic J, Mrdovic I, Tesic BV, Stojanovic R, Milic N, Simic D, Vasiljevic Z. Lasica RM, et al. Int Heart J. 2006 Jul;47(4):585-95. doi: 10.1536/ihj.47.585. Int Heart J. 2006. PMID: 16960413 Free article.

4

Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.

Mrdovic IB, Savic LZ, Perunicic JP, Asanin MR, Lasica RM, Jelena MM, Matic MD, Vasiljevic ZM, Ostojic MC. Mrdovic IB, et al. Among authors: lasica rm. Am Heart J. 2007 Jul;154(1):116-22. doi: 10.1016/j.ahj.2007.03.049. Am Heart J. 2007. PMID: 17584563 Clinical Trial.

5

Carvedilol increases copper-zinc superoxide dismutase activity in patients with acute myocardial infarction.

Kastratović DA, Vasiljević ZM, Spasić MB, Perunicić JP, Matić M, Blagojević DP, Mijalković DN, Antonijević NM, Marković SZ, Gojković-Bukarica L, Stojiljkovic MP, Lasica RM, Jones DR, Nikolić-Kokić AL. Kastratović DA, et al. Among authors: lasica rm. Basic Clin Pharmacol Toxicol. 2007 Aug;101(2):138-42. doi: 10.1111/j.1742-7843.2007.00094.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17651317 Free article. Clinical Trial.

6

Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.

Mrdovic I, Savic L, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. J Interv Cardiol. 2009 Aug;22(4):320-8. doi: 10.1111/j.1540-8183.2009.00476.x. Epub 2009 Jun 8. J Interv Cardiol. 2009. PMID: 19515084 Free article.

7

Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention.

Savic L, Mrdovic I, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Savic L, et al. J Invasive Cardiol. 2010 Jul;22(7):307-11. J Invasive Cardiol. 2010. PMID: 20603501

8

Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score.

Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Lasica R, Marinkovic J, Kocev N, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Int J Cardiol. 2013 Jan 20;162(3):220-7. doi: 10.1016/j.ijcard.2011.05.071. Epub 2011 Jun 12. Int J Cardiol. 2013. PMID: 21663982 Clinical Trial.

9

Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention.

Savic L, Mrdovic I, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Savic L, et al. J Interv Cardiol. 2012 Apr;25(2):132-9. doi: 10.1111/j.1540-8183.2011.00698.x. Epub 2011 Nov 21. J Interv Cardiol. 2012. PMID: 22103669 Free article.

10

Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.

Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Coron Artery Dis. 2012 Jan;23(1):1-8. doi: 10.1097/MCA.0b013e32834df552. Coron Artery Dis. 2012. PMID: 22107800 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters